A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro

Published:2018 Issue:5 Volume:43 Page:1677-1687
ISSN:1420-4096
Container-title:Kidney and Blood Pressure Research
language:en
Short-container-title:Kidney Blood Press Res

Author:

Liu Jian-Hua,He Long,Zou Zhi-Miao,Ding Zuo-Chuan,Zhang Xue,Wang Hao,Zhou Ping,Xie Lin,Xing Shuai,Yi Cheng-Zhi

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Nephrology,Cardiology and Cardiovascular Medicine,Nephrology

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol reinforces the therapeutic effect of mesenchymal stem cell (MSC)-derived exosomes against renal ischemia‒reperfusion injury (RIRI)-associated fibrosis by suppressing TGF-β-induced epithelial-mesenchymal transition;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease;PNAS Nexus;2024-06-28

3. MyD88 and Its Inhibitors in Cancer: Prospects and Challenges;Biomolecules;2024-05-07

4. MyD88 signaling pathways: role in breast cancer;Frontiers in Oncology;2024-01-29

5. Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway;Applied Biological Chemistry;2024-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP